Metra gets Japanese reimbursement for bone test:
This article was originally published in Clinica
Japan's Ministry of Health and Welfare has agreed to reimburse Metra Biosystems' Osteolinks-DPD bone resorption test. The test, which will be marketed by Sumitomo Pharmaceuticals, is the first product to be launched by Metra in Japan. California-based Metra says that Bayer and Abbott will both launch assays using its DPD technology in the near future.